Alterity Therapeutics (PRNAD) Assets (2009 - 2025)

Alterity Therapeutics (PRNAD) has reported Assets for 16 consecutive years, with $37.4 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Assets rose 441.83% year-over-year to $37.4 million; the TTM figure through Dec 2025 stood at $37.4 million (up 441.83% YoY), while the FY2025 annual figure was $29.5 million, up 132.67% from the prior year.
• Assets came in at $37.4 million for Q4 2025 at Alterity Therapeutics, up from $29.5 million in the prior quarter.
• The five-year high for Assets was $37.4 million in Q4 2025, with the low at $273176.4 in Q2 2023.
• Average Assets over 5 years is $21.1 million, with a median of $23.9 million recorded in 2022.
• Across the five-year window, Assets plunged 99.08% in 2023 and soared 4537.63% in 2024, its largest moves.
• Year by year, Assets stood at $32.7 million in 2021, then plunged by 32.99% to $21.9 million in 2022, then slumped by 34.13% to $14.4 million in 2023, then tumbled by 52.26% to $6.9 million in 2024, then surged by 441.83% to $37.4 million in 2025.
• According to Business Quant data, Assets over the past three periods registered $37.4 million, $29.5 million, and $6.9 million for Q4 2025, Q2 2025, and Q4 2024 respectively.